Chief Executive Officer of DiNovA Medtech, China
Chief Executive Officer of DiNovA Medtech, China
Michael has over twenty years of experience in general management at multinational medtech or lifescience corporations across major global markets such as US, Europe, Australia and China.
From 1998 to 2007, Michael held several senior management positions at Johnson & Johnson Medical’s Cordis Corporation, including the global project manager of Cordis USA, European marketing manager of Cordis Belgium, group marketing manager of Cordis Australia, and general manager of Cordis China. Michael earned numerous awards, including the Marketing Person of the Year of Johnson & Johnson Medical Australia in 2000, and multiple regional awards for Outstanding Business Performance for three consecutive years in 2002, 2003 and 2004 of Johnson & Johnson Medical Asia Pacific.
From 2010-2014, as Executive Director and CEO of Lifetech Scientific, Michael played a critical role in the IPO of Lifetech Scientific in Hong Kong in 2011 and the follow on 30-fold increase of market value. Michael also led the strategic collaboration with Medtronic, the activities of which include: Medtronic purchased 19% of Lifetech’s shares; Medtronic distributed Lifetech’s heart valve products in China; Medtronic distributed Lifetech’s LAA occluder products in 21 European countries, etc.